Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S.
Maria Di BartolomeoAlessandra RaimondiFabiola CecchiDaniel V T CatenacciSarit SchwartzShankar SellappanYuan TianRosalba MiceliAlessandro PellegrinelliElisa GiommoniEnrico AitiniFrancesca SpadaGerardo RosatiAlberto MarchetFrancesca PucciAlberto ZaniboniStefano TamberiTiziana PressianiGianni SannaMaurizio CantoreStefania MosconiPaola BolzoniCarmine PintoLorenza LandiHector Josè Soto ParraLuigi CavannaSalvatore CoralloAntonia MartinettiTodd A HembroughFilippo PietrantonioPublished in: Tumori (2020)
The quantification of TUBB3 might be considered as a negative predictive biomarker of benefit from taxane-based therapy in GC. Studies are needed to evaluate its role in the neoadjuvant setting.